Abstract
The Cardiac Arrhythmia Suppression Trial (CAST) was a landmark NHLBI-sponsored study designed to test the hypothesis that the suppression of asymptomatic or mildly symptomatic ventricular premature complexes (PVCs) in survivors of myocardial infarction (MI) would decrease the number of deaths from ventricular arrhythmias and improve survival. Enrollment required an acute MI within the preceding 2 years and 6 or more PVCs per hour during a pre-treatment (qualifying) long-term ECG (Holter) recording. Those subjects enrolled within 90 days of the index MI were required to have left ventricular ejection fractions less than or equal to 55%, while
Catalogue metadata
- Record ID
- AISLI-R-5731993399961EFDBC4C
- Type
- Datasets
- Source catalogue
- registry.opendata.aws
- Tema
- 生命科学与生物医学
- Condiciones de uso
- Open Data Commons Attribution License v1.0